Valproic acid Completed Phase 3 Trials for Depression, Bipolar Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00868452Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)